How to buy AdaptHealth stock | $26.19

AdaptHealth Corp is a medical devices business based in the US. AdaptHealth shares (AHCO) are listed on the NASDAQ and all prices are listed in US Dollars. AdaptHealth employs 4,700 staff and has a trailing 12-month revenue of around 0.00.

AdaptHealth stock price (NASDAQ: AHCO)

Use our graph to track the performance of AHCO stocks over time.

AdaptHealth shares at a glance

• Key figures

Information last updated 2021-07-23.

Latest market close	$26.19
52-week range	$18.44 - $39.76
50-day moving average	$26.99
200-day moving average	$31.27
Wall St. target price	$42.22
PE ratio	N/A
Dividend yield	N/A (0%)
Earnings per share (TTM)	$-0.66

Buy AdaptHealth shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.

*Signup bonus information updated weekly.

Is it a good time to buy AdaptHealth stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Technical Analysis of AdaptHealth Corp by TradingView

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

AdaptHealth price performance over time

Historical closes compared with the close of $26.19 from 2021-05-28

1 week (2021-07-18)	N/A
1 month (2021-06-29)	-6.06%
3 months (2021-04-29)	-11.85%
6 months (2021-01-25)	N/A

1 year (2020-07-25)	N/A
2 years (2019-07-25)	N/A
3 years (2018-07-25)	N/A
5 years (2016-07-25)	N/A

Is AdaptHealth under- or over-valued?

Valuing AdaptHealth stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of AdaptHealth's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

AdaptHealth's EBITDA

AdaptHealth's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $239 million.

The EBITDA is a measure of a AdaptHealth's overall financial performance and is widely used to measure a its profitability.

AdaptHealth financials

Revenue TTM	$1.3 billion
Operating margin TTM	9.41%
Gross profit TTM	$191.3 million
Return on assets TTM	3.06%
Return on equity TTM	-16.82%
Profit margin	-9.73%
Book value	$13.82
Market capitalisation	$2.9 billion

TTM: trailing 12 months

Shorting AdaptHealth shares

There are currently 3.2 million AdaptHealth shares held short by investors – that's known as AdaptHealth's "short interest". This figure is 15.1% down from 3.7 million last month.

There are a few different ways that this level of interest in shorting AdaptHealth shares can be evaluated.

AdaptHealth's "short interest ratio" (SIR)

AdaptHealth's "short interest ratio" (SIR) is the quantity of AdaptHealth shares currently shorted divided by the average quantity of AdaptHealth shares traded daily (recently around 921385.38011696). AdaptHealth's SIR currently stands at 3.42. In other words for every 100,000 AdaptHealth shares traded daily on the market, roughly 3420 shares are currently held short.

However AdaptHealth's short interest can also be evaluated against the total number of AdaptHealth shares, or, against the total number of tradable AdaptHealth shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case AdaptHealth's short interest could be expressed as 0.02% of the outstanding shares (for every 100,000 AdaptHealth shares in existence, roughly 20 shares are currently held short) or 0.0435% of the tradable shares (for every 100,000 tradable AdaptHealth shares, roughly 44 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against AdaptHealth.

Find out more about how you can short AdaptHealth stock.

AdaptHealth share dividends

We're not expecting AdaptHealth to pay a dividend over the next 12 months.

AdaptHealth overview

AdaptHealth Corp. , together with its subsidiaries, provides home healthcare equipment, medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; home medical equipment (HME) to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME medical devices and supplies on behalf of chronically ill patients with diabetes care, wound care, urological, ostomy, and nutritional supply needs. It serves beneficiaries of Medicare, Medicaid, and commercial payors. The company is headquartered in Plymouth Meeting, Pennsylvania. .

Frequently asked questions

What percentage of AdaptHealth is owned by insiders or institutions?
Currently 32.963% of AdaptHealth shares are held by insiders and 65.185% by institutions. How many people work for AdaptHealth?
Latest data suggests 4,700 work at AdaptHealth. When does the fiscal year end for AdaptHealth?
AdaptHealth's fiscal year ends in December. Where is AdaptHealth based?
AdaptHealth's address is: 220 West Germantown Pike, Plymouth Meeting, PA, United States, 19462 What is AdaptHealth's ISIN number?
AdaptHealth's international securities identification number is: US00653Q1022 What is AdaptHealth's CUSIP number?
AdaptHealth's Committee on Uniform Securities Identification Procedures number is: 00653Q102